Patent directory · USPTO A61K / A61P
Patents matching “immunotherapy”
175 pharma patents match "immunotherapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 175 pharmaceutical patents matching "immunotherapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12083113
Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients
granted -
US 12031157
Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 12024718
Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 12025615
Methods of classifying response to immunotherapy for cancer
granted -
US 11998568
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 11969499
Hydrogel delivery of sting immunotherapy for treatment cancer
granted -
US 11971410
Methods of classifying response to immunotherapy for cancer
granted -
US 11939596
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 11925663
Methods of managing tumor flare in adoptive immunotherapy
granted -
US 11919937
T cell receptors for immunotherapy
granted -
US 11866688
Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 11819516
Immunotherapy
granted -
US 11699503
Methods of identifying and treating patient populations amenable to cancer immunotherapy
granted -
US 11680244
Method for generating human dendritic cells for immunotherapy
granted -
US 11648302
Indoleamine 2,3-dioxygenase based immunotherapy
granted -
US 11642401
Activation of resident memory T cells for cancer immunotherapy
granted -
US 11640848
Immunotherapy methods for patients whose tumors carry a high passenger gene mutation burden
granted -
US 11631483
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
granted -
US 11591402
Neutralizing antibodies to the alpha v beta 8 integrin complex for immunotherapy
granted -
US 11578371
Biomarkers for predicting tumor response to and toxicity of immunotherapy
granted -
US 11541077
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 11529372
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 11517592
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 11504426
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist
granted